The Biotechnology Innovation Organization IP Counsels Committee will be offering the next installment in its webinar series on January 26, 2022 at 1:00 pm (ET). In the webinar, entitled "Navigating Parallel BPCIA and PTAB Proceedings – Recent Developments and Strategic Considerations," Matthew A. Pearson and Rachel J. Elsby of Akin Gump will moderate a panel consisting of Paul Golian of Bristol Myers Squibb and Paula Fritsch of Amgen. The panel will discuss recent developments in BPCIA litigation, PTAB practice, and potential legislative and policy reforms that may be on the horizon, including strategic considerations that influence how to approach the "patent dance" and parallel PTAB proceedings, as well as the impact of Fintiv on parallel proceedings. The panel will also provide a high-level overview of relevant case law and trends in BPCIA litigation and related PTAB proceedings, followed by a "roundtable" discussion of the factors that may influence litigation strategy, early case resolution, and market entry.
The webinar is complimentary for BIO members and $99 for non-members. Those interested in registering for the program, can do so here.
Comments